Clearbridge acquires 89.6% stake in Indonesia's IGM Labs for $9.4 mil

Clearbridge acquires 89.6% stake in Indonesia's IGM Labs for $9.4 mil

By: 
PC Lee
03/04/19, 07:29 pm

SINGAPORE (Apr 3): Clearbridge Health is acquiring a 89.6% stake in IGM Labs of Indonesia for $9.4 million or 2.8 times its EV/EBITDA.

See also: Clearbridge Health started at ‘buy’ with 28 cents target by Phillip on growth trajectory

The sale and purchase agreement was signed between Clearbridge’s wholly-owned subsidiary SAM Laboratory and seller PT Kreasi Putra Nusantara.

IGM Labs provides lab testing services by partnering with medical device equipment manufacturers and hospitals. Through joint agreements, IGM Labs also operates labs located with partnering hospitals.

In addition to managing a laboratory under an existing joint operation contract, 12 contracts for the operation of laboratories in public hospitals held by PT Indofarma Global Medika will also be transferred to IGM Labs under the acquisition deal.

For the FY ended Dec 2017, the 12 contracts have generated a total revenue of $14.7 million, EBITDA of $3.8 million and net profit after tax of $1.3 million, says Clearbridge.

In addition, IGM Labs is also reimbursed by Indonesia’s social security department, to provide lab testing services under its universal medical healthcare plan.

Shares in Clearbridge Health closed 2.2 cents higher at 19 cents on Wednesday.

Right timing: STI’s upclimb supported by momentum and moving averages

SINGAPORE (Apr 20): There has been little change in the trend and chart pattern of the Straits Times Index. The index has been on a very glacial ascent towards 3,420, the target indicated when the index broke out of resistance at 3,190 in mid-Jan. Quarterly momentum eased during the past four trading sessions. The 100- and 200-day moving averages have turned positive. This coupled with positively placed DIs and rising ADX should continue to underpin the STI. The only cautionary signals are the somewhat overbought levels of short term stochastics and 21-day RSI, and stagnant vol....
Read More >>

SMI takes legal action against Hyflux; Maybank moves on Tuaspring

(Apr 20): SM Investments (SMI) has terminated its rescue agreement with Hyflux, it announced on Friday. Hyflux, on its part, had already on April 4 terminated the same agreement with SMI. SMI claims it has thus far abided by the agreement. “To clarify, SMI does not accept the purported termination of the Restructuring Agreement by Hyflux on 4 April 2019. This is because the termination was not in accordance with the terms of the Restructuring Agreement," said SMI. Under the agreement reached last October, SMI, led by Indonesian tycoon Anthoni Salim, was to have invested $530 million in....
Read More >>

CCT reports 3.8% higher 1Q DPU of 2.20 cents on higher property contributions

SINGAPORE (April 19): The manager of CapitaLand Commercial Trust (CCT) has reported a 1Q19 distribution per unit (DPU) of 2.20 cents, rising 3.8% y-o-y from 2.12 cents due to higher contributions from Gallileo and Asia Square Tower 2. Gross revenue and net property income (NPI) for the quarter increased by 3.5% and 3.4% to $99.8 million and $79.8 million, respectively. This comes after booking contributions from Gallileo – an office building in Frankfurt, Germany which the trust acquired a 94.9% stake in during June 2018 – as well as higher occupancy at Asia Square Tower 2, both of w....
Read More >>